Completed PHASE3 INTERVENTIONAL 2-arm NCT01968941

Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients (LUSTRE)

A Randomized Trial of Medically-Inoperable Stage 1 Non-small Cell Lung Cancer Patients Comparing Stereotactic Body Radiotherapy Versus Conventional Radiotherapy

Sponsor: Canadian Cancer Society (CCS)

Conditions Non-small Cell Lung Cancer

Interventions Conventional Radiotherapy (CRT) Stereotactic Body Radiotherapy (SBRT)

Updated 15 times since 2017 Last updated: Sep 19, 2022 Started: May 7, 2014 Primary completion: Feb 28, 2022 Completion: May 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01968941, this PHASE3 trial focuses on Non-small Cell Lung Cancer and remains completed. Sponsored by Canadian Cancer Society (CCS), it has been updated 15 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

15 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Sep 2022 — Jul 2024 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed
May 2022 — Sep 2022 [monthly]

Active Not Recruiting PHASE3
Jan 2022 — May 2022 [monthly]

Active Not Recruiting PHASE3

▶ Show 10 earlier versions

Mar 2021 — Jan 2022 [monthly]

Active Not Recruiting PHASE3
Jan 2021 — Mar 2021 [monthly]

Active Not Recruiting PHASE3
Jan 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE3

Status: Recruiting → Active Not Recruiting
Dec 2019 — Jan 2020 [monthly]

Recruiting PHASE3
Apr 2019 — Dec 2019 [monthly]

Recruiting PHASE3
Jun 2018 — Apr 2019 [monthly]

Recruiting PHASE3
Apr 2018 — Jun 2018 [monthly]

Recruiting PHASE3
Dec 2017 — Apr 2018 [monthly]

Recruiting PHASE3
Sep 2017 — Dec 2017 [monthly]

Recruiting PHASE3
Jan 2017 — Sep 2017 [monthly]

Recruiting PHASE3

First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Canadian Cancer Society (CCS)
Ontario Clinical Oncology Group (OCOG)

Data source: Ontario Clinical Oncology Group (OCOG)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Calgary, Canada , Edmonton, Canada , Greenfield Park, Canada , Hamilton, Canada , Kingston, Canada , London, Canada , Montreal, Canada , Regina, Canada , Saint John, Canada , Saskatoon, Canada and 4 more locations